Concepedia

Chipman Stroud

CS

Statistics

Publications

3

Citations

377

H-Index

3

Active since

1997

Affiliations

University Hospital of Lausanne(Current)

Chipman Stroud is an author at University Hospital of Lausanne specializing in immunology, c-reactive protein testing, and antibody characterization.

Publications per year

1997–2025

3

Publications

3

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman Stroud, Aparna Hegde, Cynthia R. Cherry et al. · Journal of Oncology Pharmacy Practice · 2017 · 328 citations

, , +17

Analysis of Antibody-Dependent Cell-Mediated Cytotoxicity in Autoimmune Thyroid Disease

R. A. Metcalfe, Youngju Oh, Chipman Stroud et al. · Autoimmunity · 1997 · 29 citations

, , +16

Abstract CT051: SKYSCRAPER-01: A phase III, randomized trial of tiragolumab (tira) + atezolizumab (atezo) versus placebo (pbo) + atezo in patients (pts) with previously-untreated PD-L1-high, locally advanced unresectable/metastatic NSCLC

Solange Peters, Roy S. Herbst, Hidehito Horinouchi et al. · Cancer Research · 2025 · 20 citations

, , +12

1–3 of 3